BCDA Tambahing bathi saben saham ing taun lumaku BioCardia Inc

Simbol resmi perusahaan biocardia.com (BCDA)

Patent protection for myocardial cell delivery methods and stringent FDA regulations create a robust defensive barrier for BioCardia, Inc. (BCDA). The annual net income per share trend reflects a local pattern where the value of 49.50 serves as the current metric. Leadership in cell therapy via the CardiAMP platform is constrained by geopolitical risks, which are hindering European research and global expansion.

BCDA - Wutah bathi ing taun lumaku BioCardia, Inc ing rentang 04.07.2022 - 10.11.2026

Rincian metrik komprehensif lan analitis BioCardia, Inc. (BCDA)

- nilai pasar lan prakiraan target analis:
Rega saham BioCardia Inc.|BCDA - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar BioCardia Inc|BCDA - Nilai Perusahaan
- rincian valuasi buku bisnis:
Ekuitas saben Saham BioCardia|BCDA - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku biocardia.com|BCDA - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Total Utang marang Modal BioCardia, Inc.|BCDA - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal biocardia.com|BCDA - Gunggung utang perusahaan|Utang-utang marang aset resik BioCardia Inc|BCDA - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan BioCardia|Indikator likuiditas cepet biocardia.com
- statistik bathi lan rasio pasar:
BCDA - Penghasilan resik|Prakiraan bathi perusahaan BioCardia, Inc.|BCDA - Pangali P/E|Rega marang bathi mangsa ngarep BioCardia Inc|BCDA - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BioCardia Inc|BCDA - Bathi operasional EBITDA|Bathi saben saham sajrone 12 wulan pungkasan BioCardia|BCDA - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan biocardia.com|BCDA - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep BioCardia, Inc.
Pambiji fundamental:BCDA - BioCardia Inc.
Produk asil prodhuksi biocardia.com

BioCardia, Inc. operates in the high-risk cardiology therapy development sector, where financial stability depends directly on investment efficiency. This indicator measures the annual growth rate of earnings per share, allowing for an assessment of the actual profitability of capital management. The current annual EPS volatility of 49.50 reflects the business's critical dependence on clinical trial success and liquidity shortage risks.

Pesaing utama

Regeneron Pharmaceuticals, Inc. (REGN) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku iRhythm Technologies Inc|LNTH: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku MLYS|HeartFlow, Inc. - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku KMTS (Kestra Medical)|Prakiraan wutah bathi resik saben saham ing taun iki Esperion Therapeutics, Inc. (ESPR)|Amarin Corp - Wutah bathi ing taun lumaku|AVR - Wutah bathi ing taun lumaku|TNYA (tenayatherapeutics.com) - Wutah bathi resik saben saham ing taun iki|cvrx.com - Tambahing bathi saben saham ing taun lumaku|MIST (Milestone Pharmaceuticals Inc.) - Wutah bathi ing taun lumaku|Cardiol (CRDL) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku HeartBeam Corp (BEAT)|Tenax Therapeutics Inc - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku ADGM (Adagio Medical Holdings)|VTAK - Wutah bathi resik saben saham ing taun iki|ABIO: Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun iki Acasti Pharma ACST|AVTE: Wutah bathi ing taun lumaku|VERV (Verve Therapeutics, Inc.) - Wutah bathi saben saham ing taun lumaku|WINT (Windtree Therapeutics Inc.) - Wutah bathi ing taun lumaku